SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 29 Apr · 17:34 IST

Sanofi India Limited has informed the Exchange about Copy of Newspaper Publication

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹3425.10
prior close
₹3430.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.3+0.1+0.5-0.7-0.6-0.8-1.0-2.7-5.1-7.8-8.8-0.5
Up moveDown movePending
AI summary

Sanofi India has submitted copies of newspaper advertisements of its financial results for the quarter and year ended 31st March 2026 to the stock exchanges. The results were published in Business Standard (English) and Sakal (Marathi) on 29th April 2026. This filing is being made under Regulation 30 and 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The actual financial results themselves were filed separately and approved by the board on 28th April 2026. The submission was signed by Haresh Vala, Company Secretary and Compliance Officer.

Likely market impact

This is a routine regulatory compliance filing and does not contain new financial information. Shareholders should refer to Sanofi's separately filed Q4 and FY26 results for the actual numbers, which would have been disclosed earlier. No direct impact on the stock price is expected from this particular filing.